AI-based Frailty Assessment Tool for Patients Undergoing Cardiac Surgery - Trial NCT06096922
Access comprehensive clinical trial information for NCT06096922 through Pure Global AI's free database. This phase not specified trial is sponsored by China National Center for Cardiovascular Diseases and is currently Recruiting. The study focuses on Frailty. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
China National Center for Cardiovascular Diseases
Timeline & Enrollment
N/A
Nov 01, 2023
Dec 01, 2024
Primary Outcome
One-dimensional matrix vector composed of five frailty scale results
Summary
The main purpose of this study is to establish a frailty automatic evaluation index AI
 frailty index based on artificial intelligence multi-modal non-contact monitoring
 information analysis. At the same time, the study will explore the correlation between ' AI
 weakness index ' and perioperative and long-term prognosis and quality of life.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06096922
Non-Device Trial